Join Us Live for a Discussion on Medicare, Democracy, and the Future of Health Care
The Inflation Reduction Act (IRA) takes important steps to reduce drug prices and lower costs for people with Medicare and the program, such as capping beneficiary out-of-pocket spending; requiring Medicare to negotiate drug prices; and expanding eligibility for the full Part D low-income subsidy (LIS). We support an implementation process that centers the beneficiary experience and look forward to building upon these landmark policies.
KFF has released a new issue brief previewing expected savings for millions of Medicare Part D enrollees starting in 2025
On February 1, the U.S. Department of Health and Human Services (HHS) sent initial offers to manufacturers of the first
Beginning this year, the Inflation Reduction Act (IRA) expands eligibility for the Part D Low Income Subsidy (LIS), also called
The Medicare Rights Center commented on the Contract Year 2025 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly proposed rule.
A newly effective Inflation Reduction Act (IRA) provision is improving prescription drug affordability for many people with Medicare Part D
Last month, the office of the Assistant Secretary for Planning and Evaluation (ASPE), a research arm of the Department of
Last week, the Medicare Rights Center joined with other advocacy organizations to urge a federal court to reject claims by
The Medicare Rights Center (Medicare Rights) appreciates this opportunity to comment on the Medicare Prescription Payment Plan (MPPP) draft guidance. Medicare Rights is a national, nonprofit organization that works to ensure access to affordable and equitable health care for older adults and people with disabilities through counseling and advocacy, educational programs, and public policy initiatives. Each year, Medicare Rights provides services and resources to over three million people with Medicare, family caregivers, and professionals.
Last month, the Government Accountability Office (GAO) recommended that the Centers for Medicare & Medicaid Services monitor the effects of
KFF has released a new issue brief previewing expected savings for millions of Medicare Part D enrollees starting in 2025
On February 1, the U.S. Department of Health and Human Services (HHS) sent initial offers to manufacturers of the first
Beginning this year, the Inflation Reduction Act (IRA) expands eligibility for the Part D Low Income Subsidy (LIS), also called
The Medicare Rights Center commented on the Contract Year 2025 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly proposed rule.
A newly effective Inflation Reduction Act (IRA) provision is improving prescription drug affordability for many people with Medicare Part D
Last month, the office of the Assistant Secretary for Planning and Evaluation (ASPE), a research arm of the Department of
Last week, the Medicare Rights Center joined with other advocacy organizations to urge a federal court to reject claims by
The Medicare Rights Center (Medicare Rights) appreciates this opportunity to comment on the Medicare Prescription Payment Plan (MPPP) draft guidance. Medicare Rights is a national, nonprofit organization that works to ensure access to affordable and equitable health care for older adults and people with disabilities through counseling and advocacy, educational programs, and public policy initiatives. Each year, Medicare Rights provides services and resources to over three million people with Medicare, family caregivers, and professionals.
Last month, the Government Accountability Office (GAO) recommended that the Centers for Medicare & Medicaid Services monitor the effects of
